Cardiomyopathy/Myocarditis
RSSArticles
-
Study Identifies Incidence and Origin of PEA
Over the last twenty years, the proportion of cardiac-arrest victims in whom pulseless electric activity (PEA) is identified rather than asystole or ventricular fibrillation as the initial ECG finding has been increasing. -
Omeprazole and Clopidogrel — Is There a Clinically Meaningful Interaction?
Gastrointestinal (GI) bleeding is a major complication of dual anti-platelet therapy (DAPT) with aspirin and clopidogrel. -
Finding the Value of High-sensitivity Troponin Assays
New high-sensitivity cardiac troponin assays detect blood levels in many patients with chronic heart failure or ischemic heart disease who do not meet clinical criteria for myocardial infarction. -
Colchicine Prevents Post-pericardiotomy Syndrome
Post-pericardiotomy syndrome (PPS) is relatively common after cardiac surgery, and can result in life-threatening events, such as cardiac tamponade, increased length of stay, readmission to hospital, and significant patient discomfort. -
New Study Supports More Appropriate Blood Pressure Levels for Post-ACS Patients
The relationship between blood pressure and cardiovascular events remains controversial, especially in patients with coronary artery disease who may need increased pressures to have adequate myocardial perfusion. -
The Value of Family History in CAD
Although a routine part of the patient’s medical history, little is known about the value of family history in predicting coronary artery disease (CAD) events in otherwise low-risk patients. -
FFR in Coronary Lesion Assessment: When is Negative Truly Negative?
Fractional flow reserve (FFR) is an invasive technique for determination of the physiologic significance of an intermediate coronary lesion. Multiple studies have demonstrated the ability of FFR to guide revascularization decisions. -
Clinical Value of Handheld Echocardiography
Small handheld ultrasound units are being deployed in emergency departments and other sites to aide in point-of-care cardiac diagnosis. -
Value of ECG LVH in Aortic Stenosis
Progressive, compensatory left ventricular hypertrophy (LVH) in aortic stenosis (AS) ultimately leads to myocardial injury, fibrosis, and LV dysfunction. -
Thienopyridine Pretreatment in Patients with Non-ST Elevation Acute Coronary Syndromes: Where’s the Evidence?
In their recent meta-analysis, Bellemain-Appaix and colleagues looked at thienopyridine (P2Y12 inhibitor) pretreatment in seven studies that included primarily NSTEACS patients, including four randomized, controlled trials and three registries. In the overall cohort, pretreatment did not reduce the risk of all-cause mortality or cardiovascular death. Major adverse cardiovascular events were reduced in the pretreatment group (odds ratio [OR], 0.84; 95% confidence interval [CI] 0.72 to 0.98; P = 0.02), but individual endpoints, such as myocardial infarction, were not significantly affected. Among the subset of patients who underwent percutaneous coronary intervention (PCI), which represented a minority of the total cohort, there was likewise no reduction in death or cardiovascular death, but pretreatment with P2Y12 inhibitors was associated only with a non-significant trend toward a reduction of major adverse cardiac events (MACE). Within the PCI group, pretreatment was associated with a reduction of urgent revascularization (OR, 0.72; 95% CI, 0.52 to 1.00); however, this result was driven primarily by the results of the PCI subset of the CURE, in which the delay from admission to revascularization averaged a relatively long 10 days.